{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-001119","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.091487+00:00","generated_at":"2026-06-05T05:14:25.025311+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"United-Guardian entered into manufacturing & supply agreement with Amsino for Renacidin Irrigation","bullets":["Agreement with Amsino Healthcare (USA) effective Jan 1, 2023 for manufacture and supply of Renacidin Irrigation.","Initial term of 6 years with automatic renewal for two successive 2-year periods.","Company will supply raw materials; Amsino manufactures, tests, releases, and ships product.","Customary provisions for regulatory compliance, quality control, indemnification, confidentiality."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-001119","json":"https://secwatch.observer/filing/0001171843-24-001119.json","markdown":"https://secwatch.observer/filing/0001171843-24-001119.md","text":"https://secwatch.observer/filing/0001171843-24-001119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184324001119/0001171843-24-001119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184324001119/f8k_022924.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:14:25.025311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"011f67a4b686dcff2d6404702900a02c40ef8895","claim":"UNITED GUARDIAN INC entered into Manufacturing and Supply Agreement with Amsino Healthcare (USA), Inc. (effective 2023-03-30).","evidence_excerpt":"On March 30, 2023, United-Guardian, Inc. (the “Company”) entered into a manufacturing and supply agreement with Amsino Healthcare (USA), Inc. (“Amsino”), the successor in interest to Smiths Medical, effective as of January 1, 2023 (the “Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/101295/000117184324001119/0001171843-24-001119-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"Amsino Healthcare (USA), Inc."},{"label":"Effective","value":"2023-03-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}